Interim e-Janus data back Sorin's DES (Drug-eluting stent)
This article was originally published in Clinica
Executive Summary
Sorin Group's "real-world" registry of its tacrolimus-eluting stent, Janus, has produced positive interim results at a six-month follow-up mark.